富士製薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/05/23 | 1,283 | 1,285 | 1,276 | 1,285 | +8 | +0.6% | 19,700 |
| 2025/05/22 | 1,277 | 1,295 | 1,277 | 1,277 | -8 | -0.6% | 39,300 |
| 2025/05/21 | 1,281 | 1,293 | 1,280 | 1,285 | +18 | +1.4% | 46,600 |
| 2025/05/20 | 1,277 | 1,289 | 1,267 | 1,267 | -7 | -0.5% | 63,400 |
| 2025/05/19 | 1,263 | 1,281 | 1,255 | 1,274 | +10 | +0.8% | 73,300 |
| 2025/05/16 | 1,253 | 1,271 | 1,253 | 1,264 | +11 | +0.9% | 36,400 |
| 2025/05/15 | 1,251 | 1,263 | 1,233 | 1,253 | -3 | -0.2% | 82,500 |
| 2025/05/14 | 1,270 | 1,270 | 1,244 | 1,256 | -17 | -1.3% | 98,000 |
| 2025/05/13 | 1,308 | 1,317 | 1,271 | 1,273 | -29 | -2.2% | 106,100 |
| 2025/05/12 | 1,310 | 1,313 | 1,292 | 1,302 | -8 | -0.6% | 64,600 |
| 2025/05/09 | 1,301 | 1,337 | 1,301 | 1,310 | -65 | -4.7% | 174,100 |
| 2025/05/08 | 1,390 | 1,392 | 1,354 | 1,375 | +7 | +0.5% | 87,300 |
| 2025/05/07 | 1,359 | 1,397 | 1,343 | 1,368 | +7 | +0.5% | 148,600 |
| 2025/05/02 | 1,365 | 1,372 | 1,348 | 1,361 | +4 | +0.3% | 28,200 |
| 2025/05/01 | 1,362 | 1,366 | 1,351 | 1,357 | -9 | -0.7% | 23,500 |
| 2025/04/30 | 1,375 | 1,375 | 1,357 | 1,366 | -4 | -0.3% | 22,800 |
| 2025/04/28 | 1,355 | 1,381 | 1,355 | 1,370 | +15 | +1.1% | 23,500 |
| 2025/04/25 | 1,355 | 1,370 | 1,355 | 1,355 | ±0 | ±0% | 24,300 |
| 2025/04/24 | 1,368 | 1,371 | 1,354 | 1,355 | -7 | -0.5% | 25,300 |
| 2025/04/23 | 1,353 | 1,370 | 1,347 | 1,362 | +10 | +0.7% | 33,600 |
| 2025/04/22 | 1,342 | 1,355 | 1,335 | 1,352 | +22 | +1.7% | 31,000 |
| 2025/04/21 | 1,326 | 1,332 | 1,314 | 1,330 | -8 | -0.6% | 20,300 |
| 2025/04/18 | 1,322 | 1,340 | 1,308 | 1,338 | +35 | +2.7% | 36,500 |
| 2025/04/17 | 1,314 | 1,315 | 1,295 | 1,303 | -14 | -1.1% | 29,500 |
| 2025/04/16 | 1,337 | 1,341 | 1,309 | 1,317 | ±0 | ±0% | 39,100 |
| 2025/04/15 | 1,301 | 1,321 | 1,301 | 1,317 | +22 | +1.7% | 32,100 |
| 2025/04/14 | 1,292 | 1,309 | 1,285 | 1,295 | +27 | +2.1% | 42,800 |
| 2025/04/11 | 1,257 | 1,276 | 1,238 | 1,268 | -38 | -2.9% | 66,100 |
| 2025/04/10 | 1,315 | 1,320 | 1,290 | 1,306 | +50 | +4% | 61,500 |
| 2025/04/09 | 1,232 | 1,270 | 1,232 | 1,256 | +7 | +0.6% | 159,900 |
| 2025/04/08 | 1,241 | 1,249 | 1,206 | 1,249 | +68 | +5.8% | 102,900 |
| 2025/04/07 | 1,193 | 1,225 | 1,180 | 1,181 | -72 | -5.7% | 147,600 |
| 2025/04/04 | 1,283 | 1,283 | 1,229 | 1,253 | -42 | -3.2% | 132,900 |
| 2025/04/03 | 1,261 | 1,301 | 1,261 | 1,295 | -20 | -1.5% | 66,600 |
| 2025/04/02 | 1,346 | 1,346 | 1,313 | 1,315 | -22 | -1.6% | 55,800 |
| 2025/04/01 | 1,343 | 1,356 | 1,337 | 1,337 | +1 | +0.1% | 42,600 |
| 2025/03/31 | 1,378 | 1,378 | 1,331 | 1,336 | -53 | -3.8% | 79,600 |
| 2025/03/28 | 1,399 | 1,404 | 1,385 | 1,389 | -30 | -2.1% | 47,100 |
| 2025/03/27 | 1,408 | 1,419 | 1,396 | 1,419 | +7 | +0.5% | 60,000 |
| 2025/03/26 | 1,400 | 1,414 | 1,398 | 1,412 | +15 | +1.1% | 54,300 |
| 2025/03/25 | 1,389 | 1,399 | 1,383 | 1,397 | +3 | +0.2% | 40,700 |
| 2025/03/24 | 1,410 | 1,410 | 1,383 | 1,394 | -8 | -0.6% | 52,500 |
| 2025/03/21 | 1,399 | 1,402 | 1,388 | 1,402 | +3 | +0.2% | 43,800 |
| 2025/03/19 | 1,384 | 1,405 | 1,376 | 1,399 | +26 | +1.9% | 52,600 |
| 2025/03/18 | 1,365 | 1,384 | 1,365 | 1,373 | +9 | +0.7% | 47,600 |
| 2025/03/17 | 1,362 | 1,368 | 1,352 | 1,364 | +12 | +0.9% | 39,300 |
| 2025/03/14 | 1,350 | 1,359 | 1,346 | 1,352 | -4 | -0.3% | 40,900 |
| 2025/03/13 | 1,344 | 1,361 | 1,343 | 1,356 | +12 | +0.9% | 50,300 |
| 2025/03/12 | 1,342 | 1,344 | 1,334 | 1,344 | +1 | +0.1% | 32,800 |
| 2025/03/11 | 1,340 | 1,344 | 1,327 | 1,343 | -3 | -0.2% | 42,000 |
1～
50
件表示中 / 6958件
類似銘柄と比較する
現在ご覧いただいている「富士製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 富士製薬 | 128,500円 | +15.7% | +5.3% | 3.54% | 9.29倍 | 0.69倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
| 生化学 | 63,900円 | -9.6% | -30.2% | 4.69% | 25.83倍 | 0.48倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
| ヘリオス | 32,900円 | +150.0% | - | 0.00% | - | 16.18倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| ダイト | 205,700円 | +4.5% | -33.7% | 3.40% | 20.56倍 | 0.59倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
| ミズホメディ | 150,100円 | +1.2% | -13.9% | 5.66% | 8.85倍 | 1.65倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
市場注目の銘柄
チャート関連のコラム
